Open AccessCOMBINATION OF METFORMIN AND EMPAGLIFLOZIN CAN CHANGES GUT MICROBIOTA OF TYPE 2 DIABETIC PATIENTS WITH HYPOTHYROIDISM AND CORONARY ARTERY DISEASE
Author(s) -
Kh.A. Moskva,
O. Kikhtyak,
L. Lapovets
Publication year - 2022
Publication title -
scientific practice: modern and classical research methods
Language(s) - English
Resource type - Conference proceedings
DOI - 10.36074/logos-16.09.2022.41
Subject(s) - bacteroidetes , metformin , type 2 diabetes , medicine , firmicutes , coronary artery disease , diabetes mellitus , gut flora , gastroenterology , endocrinology , biology , immunology , bacteria , genetics , 16s ribosomal rna